Trials in Progress: A Phase I Study to Evaluate the Safety and Pharmacokinetic Profiles of CB-5339 in Participants with Relapsed/Refractory Acute Myeloid Leukemia or Relapsed/Refractory Intermediate or High-Risk Myelodysplastic Syndrome
Year: 2020
Type: conference-abstract
Source: Blood
Authors: Lina Benajiba, Hetty E. Carraway, Nada Hamad, Eytan M. Stein, Costas K. Yannakou, Amy Burroughs, Scott Harris, Hayley Lane, Dorothy D. Nguyen, Monic Stuart, Jesse Vargas, Alexandre Puissant, Kimberly Stegmaier, Courtney D. DiNardo
Institutions: Inserm, Génomes, biologie cellulaire et thérapeutiques, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Cleveland Clinic, UNSW Sydney, St Vincent's Hospital Sydney, Memorial Sloan Kettering Cancer Center, Epworth Hospital, Instacart (United States), Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095441714